Improvement of airflow limitation by fluticasone propionate/salmeterol in chronic obstructive pulmonary disease: what is the specific marker?

• Main Authors: Keiichiro eAkamatsu (Author), Kazuto eMatsunaga (Author), Hisatoshi eSugiura (Author), Akira eKoarai (Author), Tsunahiko eHirano (Author), Yoshiaki eMinakata (Author), Masakazu eIchinose (Author)
• Format: Book
• Published: Frontiers Media S.A., 2011-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Backgrounds: Inhaled corticosteroids (ICS)/inhaled long-acting beta2-agonists (LABA) combination drugs are widely used for the long-term management of COPD. However, COPD is a heterogeneous condition and treatment with ICS is associated with a higher risk of pneumonia. The identification of a specif...